Use of PLA.sub.2 inhibitors as treatment for alzheimer's disease
AssigneeEli Lilly and Company
InventorsJames A. Clemens, Michael J. Sofia, Diane T. Stephenson
Life of this patent
Estimating the term…
Abstract
This invention provides methods for the treatment or prevention of Alzheimer's disease in a mammal which comprises administering to a mammal in need thereof an effective amount of an inhibitor of phospholipase A.sub.2. This invention also provides a series of compounds which are useful as inhibitors of phospholipases A.sub.2, especially cytosolic phospholipase A.sub.2.
Claims12
A method for the treatment of Alzheimer's disease in a mammal which comprises administering to a mammal in need of said treatment an effective amount of an inhibitor of phospholipase A.sub.2 activity or a pharmaceutically acceptable salt of said inhibitor.
Dependencies are inferred from the claim text.